XBIO
Xenetic Biosciences Inc
NASDAQ: XBIO · HEALTHCARE · BIOTECHNOLOGY
$3.03
+1.00% today
Updated 2026-04-30
Market cap
$6.87M
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-1.58
Dividend yield
—
52W range
$2 – $14
Volume
0.0M
Xenetic Biosciences Inc (XBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+44.9%
Last 4 quarters
Revenue YoY growth
+18.1%
Most recent quarter
EPS YoY growth
+67.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.1%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-6.4%
2026-03-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-25 | $-0.22 | +57.7% | $2.99 | $2.80 | -6.4% |
| 2025-11-12 | $-0.33 | +60.7% | $2.73 | $2.57 | -5.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.52 | $-0.22 | +57.7% | $766296.00 | +18.1% |
| 2025-09-30 | $-0.84 | $-0.33 | +60.7% | $1.03M | +67.2% |
| 2025-06-30 | $-0.79 | $-0.45 | +43.0% | $589897.00 | -18.8% |
| 2025-03-31 | $-0.72 | $-0.59 | +18.1% | $593261.00 | +16.1% |
| 2024-12-31 | $-0.20 | $-0.68 | -240.0% | $648820.00 | -3.4% |
| 2024-09-30 | $-0.14 | $-0.28 | -100.0% | $614243.00 | +0.5% |
| 2024-06-30 | $-0.83 | $-0.83 | +0.0% | $726404.00 | +11.6% |
| 2024-03-31 | $-0.79 | $-0.78 | +1.3% | $510816.00 | -15.7% |
| 2023-12-31 | $-0.87 | $-0.77 | +11.5% | $671963.00 | — |
| 2023-09-30 | $-1.12 | $-0.69 | +38.4% | $611174.00 | — |
| 2023-06-30 | $-1.13 | $-0.69 | +38.9% | $651005.00 | — |
| 2023-03-31 | $-1.10 | $-0.60 | +45.5% | $605844.00 | — |
Frequently asked questions
Has Xenetic Biosciences Inc beaten earnings estimates?
Xenetic Biosciences Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +44.9% over the last 4 quarters.
How does XBIO stock react to earnings?
XBIO stock has moved an average of -6.1% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Xenetic Biosciences Inc's revenue growth rate?
Xenetic Biosciences Inc reported year-over-year revenue growth of +18.1% in its most recent quarter, with EPS growing +67.6% year-over-year.